Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.
摘要:
The matrix metalloproteinases (MMPs) mediate homeostasis of the extracellular environment. They have multiple signalling activities that are commonly altered during tumorigenesis and that might serve as intervention points for anticancer drugs. However, there are many criteria to consider in validating MMPs as drug targets and for the development of MMP inhibitors. The inhibition of some MMPs could have pro-tumorigenic effects (making them anti-targets), counterbalancing the benefits of target inhibition. These effects might partially account for the failure of MMP inhibitors in clinical trials. What are the major challenges in MMP target validation and MMP-inhibitor-drug development?
展开
关键词:
Extracellular Matrix Cell Transformation, Neoplastic Tissue Inhibitor of Metalloproteinases Antineoplastic Agents Protease Inhibitors Gene Expression Regulation, Enzymologic Neoplasm Invasiveness Neoplasms Neovascularization, Pathologic Forecasting
DOI:
10.1038/nrc1821
被引量:
年份:
2006



































通过文献互助平台发起求助,成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用!